The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.20 - Manufacture of pharmaceutical preparations
330 jobs Number of planned job creations
Announcement Date
2 February 2026
Employment effect (start)
1 February 2026
Foreseen end date
31 October 2026
Description
The pharmaceutical company Lek, owned by the Swiss group Sandoz, is investing in Lendava, creating 330 new jobs.
Construction is under way on a factory to manufacture active ingredients for similar biological medicines in Lendava. An investment of over €540 million will create around 330 new jobs in the Prekmurje region, including approximately 180 high value-added positions. The centre is expected to open in 2026.
Of all 3,024 employees in Lek, 27 percent are employed in Lendava. Almost two-thirds of new hires are under the age of 35, indicating a generational transition and development momentum.
Eurofound (2026), Lek, Business expansion in Slovenia, factsheet number 204204, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/204204.